Mesalazine Conjugate with Eicosapentaenoic Acid and Caprylic Acid (Cellix)

N/A

Report date: 2025/06/11 10:34:02
NME

Base Information

Drug NameMesalazine Conjugate with Eicosapentaenoic Acid and Caprylic Acid (Cellix)
Drug Alias Namemesalazine (Cellix Bio)CLX-103CIX-301CLX-SYN-G3-C03
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsProstanoid receptor antagonists
TargetsCyclooxygenasesProstanoid receptor
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellix Bio Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCellix Biosciences IncCellix Bio Pvt Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A